eMedicine Specialties > Emergency Medicine > Toxicology

Toxicity, Salicylate: Follow-up

Author: Lance W Kreplick, MD, MMM, FAAEM, FACEP, Medical Director of Hyperbaric Medicine, Fawcett Wound Management and Hyperbaric Medicine; Consulting Staff in Occupational Health and Rehabilitation, Company Care Occupational Health Services; President and Chief Executive Officer, QED Medical Solutions, LLC
Contributor Information and Disclosures

Updated: Jul 11, 2008

Follow-up

Further Inpatient Care

  • Admit patients with major signs and symptoms (eg, neurological, cardiopulmonary, metabolic) to an intensive care unit under the care of a medical toxicologist, if available. Consult psychiatric service personnel for patients with intentional overdose.
  • Admit patients with minor signs and symptoms (eg, tinnitus, nausea) to an extended care observational unit or medical floor.
  • Admit the following patients, regardless of salicylate levels:
    • Infants and elderly persons
    • Individuals with chronic salicylism
    • Those with ingestions of sustained-release products

Further Outpatient Care

  • Patients with accidental ingestions of less than 150 mg/kg and no signs of toxicity can be discharged after 6 hours postingestion. Arrange a follow-up for these patients in 24 hours.

Prognosis

  • A 16% morbidity rate and a 1% mortality rate are associated with patients presenting with an acute overdose.
  • The incidence of morbidity and mortality for a patient with chronic intoxication is 30% and 25%, respectively.

Patient Education

Miscellaneous

Medicolegal Pitfalls

  • Failure to diagnose salicylate toxicity in a patient presenting with vague signs and symptoms, such as anxiety, tachypnea, agitation, delirium, tinnitus, or a combined respiratory alkalosis and metabolic acidosis
  • Failure to initiate GI decontamination in a patient with acute salicylate ingestion who, subsequently, has recurrent toxicity from a salicylate bezoar
  • Failure to hyperventilate a patient with severe salicylate poisoning who has just been intubated (when acid-base status had been maintained previously by the patient's own hyperventilation) to prevent lethal acidemia
  • Failure to remove any possible ingestants from a patient's access when presentation follows an intentional ingestion, such as a suicide attempt
  • Failure to diagnose and treat concomitant hypoglycemia in the salicylate-intoxicated patient; more common in children than in adults
  • Failure to diagnose and treat hypoxemia caused by salicylate-induced pulmonary edema
  • Failure to consider co-ingestions or other diagnoses
  • Failure to consider recurrent or delayed toxicity from sustained-release preparations or from an unrecognized medication bezoar
 


More on Toxicity, Salicylate

Overview: Toxicity, Salicylate
Differential Diagnoses & Workup: Toxicity, Salicylate
Treatment & Medication: Toxicity, Salicylate
Follow-up: Toxicity, Salicylate
References

References

  1. Acetylsalicylic Acid. National Library of Medicine, TOXNET, Hazardous Substances Data Bank. Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~yiK5GU:1.

  2. Brenner BE, Simon RR. Management of salicylate intoxication. Drugs. Oct 1982;24(4):335-40. [Medline].

  3. Chan TY, Chan AY, Ho CS, Critchley JA. The clinical value of screening for salicylates in acute poisoning. Vet Hum Toxicol. Feb 1995;37(1):37-8. [Medline].

  4. Chapman BJ, Proudfoot AT. Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations. Q J Med. Aug 1989;72(268):699-707. [Medline].

  5. Chiaretti A, Schembri Wismayer D, Tortorolo L, et al. Salicylate intoxication using a skin ointment. Acta Paediatr. Mar 1997;86(3):330-1. [Medline].

  6. Danel V, Henry JA, Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. Br Med J (Clin Res Ed). May 28 1988;296(6635):1507. [Medline].

  7. Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J. May 2002;19(3):206-9. [Medline].

  8. Done AK, Temple AR. Treatment of salicylate poisoning. Mod Treat. Aug 1971;8(3):528-51. [Medline].

  9. Dugandzic RM, Tierney MG, Dickinson GE, et al. Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication. Ann Emerg Med. Nov 1989;18(11):1186-90. [Medline].

  10. Gabow PA, Anderson RJ, Potts DE, Schrier RW. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med. Oct 1978;138(10):1481-4. [Medline].

  11. Gilman AG, Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 6th ed. New York: McGraw-Hill; 1980.

  12. Gittelman DK. Chronic salicylate intoxication. South Med J. Jun 1993;86(6):683-5. [Medline].

  13. Johnson D, Eppler J, Giesbrecht E, Verjee Z, Rais A, Wiggins T. Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model. Ann Emerg Med. Nov 1995;26(5):569-74. [Medline].

  14. Krause DS, Wolf BA, Shaw LM. Acute aspirin overdose: mechanisms of toxicity. Ther Drug Monit. Dec 1992;14(6):441-51. [Medline].

  15. O'Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. May 2007;25(2):333-46; abstract viii. [Medline].

  16. Proudfoot AT. Toxicity of salicylates. Am J Med. Nov 14 1983;75(5A):99-103. [Medline].

  17. Teece S, Crawford I. Best evidence topic report. Gastric lavage in aspirin and non-steroidal anti-inflammatory drug overdose. Emerg Med J. Sep 2004;21(5):591-2. [Medline].

  18. Temple AR. Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med. Feb 23 1981;141(3 Spec No):364-9. [Medline].

Further Reading

Keywords

aspirin overdose, aspirin, aspirin poisoning, aspirin ingestion, salicylate toxicity, salicylate ingestion, salicylate overdose, salicylate poisoning

Contributor Information and Disclosures

Author

Lance W Kreplick, MD, MMM, FAAEM, FACEP, Medical Director of Hyperbaric Medicine, Fawcett Wound Management and Hyperbaric Medicine; Consulting Staff in Occupational Health and Rehabilitation, Company Care Occupational Health Services; President and Chief Executive Officer, QED Medical Solutions, LLC
Lance W Kreplick, MD, MMM, FAAEM, FACEP is a member of the following medical societies: American Academy of Emergency Medicine and American College of Physician Executives
Disclosure: Nothing to disclose.

Medical Editor

Mark S Slabinski, MD, FACEP, FAAEM, Vice President, EMP Medical Group
Mark S Slabinski, MD, FACEP, FAAEM is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Ohio State Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

John T VanDeVoort, PharmD, ABAT, Director of Pharmacy, Sacred Heart Hospital
John T VanDeVoort, PharmD, ABAT is a member of the following medical societies: American Academy of Clinical Toxicology and American Society of Health-System Pharmacists
Disclosure: Nothing to disclose.

Managing Editor

Fred Harchelroad, MD, FACMT, Chair, Department of Emergency Medicine, Director of Medical Toxicology, Department of Emergency Medicine, Associate Professor, Allegheny General Hospital
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD, Assistant Professor, Department of Surgery, Section of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.